What is the primary cause of anemia in chronic kidney disease?

Prepare for the HESI Chronic Kidney Disease Case Study Exam with multiple-choice questions and detailed explanations. Boost your confidence for success!

Multiple Choice

What is the primary cause of anemia in chronic kidney disease?

Explanation:
The main idea is that anemia in chronic kidney disease mostly comes from the kidneys not making enough erythropoietin, the hormone that signals the bone marrow to produce red blood cells. When erythropoietin levels fall, red blood cell production drops, leading to anemia. This is typically a normocytic, normochromic anemia and is often accompanied by a low reticulocyte count because the bone marrow isn’t being appropriately stimulated to make new red cells. Iron status frequently compounds the problem. Even when erythropoietin is low, having sufficient iron is needed for making hemoglobin. In CKD, iron deficiency can be present due to reduced intake, chronic inflammation, and blood loss during dialysis, causing a functional iron deficiency that blunts the response to therapy. That’s why management often includes both addressing erythropoietin signaling with erythropoiesis-stimulating agents and correcting iron deficiency with iron supplementation, guided by ferritin and transferrin saturation levels. Other possibilities like iron overload from transfusions, bleeding ulcers, or vitamin B12 deficiency don’t explain the typical picture of CKD-related anemia. Iron overload isn’t the driving factor, GI bleeding would be a contributing issue rather than the primary cause in this context, and B12 deficiency leads to a different, macrocytic pattern.

The main idea is that anemia in chronic kidney disease mostly comes from the kidneys not making enough erythropoietin, the hormone that signals the bone marrow to produce red blood cells. When erythropoietin levels fall, red blood cell production drops, leading to anemia. This is typically a normocytic, normochromic anemia and is often accompanied by a low reticulocyte count because the bone marrow isn’t being appropriately stimulated to make new red cells.

Iron status frequently compounds the problem. Even when erythropoietin is low, having sufficient iron is needed for making hemoglobin. In CKD, iron deficiency can be present due to reduced intake, chronic inflammation, and blood loss during dialysis, causing a functional iron deficiency that blunts the response to therapy. That’s why management often includes both addressing erythropoietin signaling with erythropoiesis-stimulating agents and correcting iron deficiency with iron supplementation, guided by ferritin and transferrin saturation levels.

Other possibilities like iron overload from transfusions, bleeding ulcers, or vitamin B12 deficiency don’t explain the typical picture of CKD-related anemia. Iron overload isn’t the driving factor, GI bleeding would be a contributing issue rather than the primary cause in this context, and B12 deficiency leads to a different, macrocytic pattern.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy